framework version 7 10 software Search Results


90
MetaMorph Inc commercial software package metamorph version 7.10.5
Commercial Software Package Metamorph Version 7.10.5, supplied by MetaMorph Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/commercial software package metamorph version 7.10.5/product/MetaMorph Inc
Average 90 stars, based on 1 article reviews
commercial software package metamorph version 7.10.5 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
SCANCO USA INC software version 7.10.1.1
Software Version 7.10.1.1, supplied by SCANCO USA INC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software version 7.10.1.1/product/SCANCO USA INC
Average 90 stars, based on 1 article reviews
software version 7.10.1.1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Bluesky Medical Group Inc statistics version 7.10 software
Statistics Version 7.10 Software, supplied by Bluesky Medical Group Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/statistics version 7.10 software/product/Bluesky Medical Group Inc
Average 90 stars, based on 1 article reviews
statistics version 7.10 software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
SoftMax Inc pro software for windows 10 version 7
Pro Software For Windows 10 Version 7, supplied by SoftMax Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pro software for windows 10 version 7/product/SoftMax Inc
Average 90 stars, based on 1 article reviews
pro software for windows 10 version 7 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
De Novo Software Inc fcs express 7 flow version 7.10.0007
Fcs Express 7 Flow Version 7.10.0007, supplied by De Novo Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fcs express 7 flow version 7.10.0007/product/De Novo Software Inc
Average 90 stars, based on 1 article reviews
fcs express 7 flow version 7.10.0007 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MetaMorph Inc software version 7.10.1.161
Software Version 7.10.1.161, supplied by MetaMorph Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software version 7.10.1.161/product/MetaMorph Inc
Average 90 stars, based on 1 article reviews
software version 7.10.1.161 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
MetaMorph Inc software version 7.10.3
Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left <t>ventricular</t> end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.
Software Version 7.10.3, supplied by MetaMorph Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/software version 7.10.3/product/MetaMorph Inc
Average 90 stars, based on 1 article reviews
software version 7.10.3 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Applied Maths bionumerics version 7.10 fingerprinting software
Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left <t>ventricular</t> end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.
Bionumerics Version 7.10 Fingerprinting Software, supplied by Applied Maths, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/bionumerics version 7.10 fingerprinting software/product/Applied Maths
Average 90 stars, based on 1 article reviews
bionumerics version 7.10 fingerprinting software - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
Becton Dickinson analysis software version 7.6.5 10.8.1
Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left <t>ventricular</t> end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.
Analysis Software Version 7.6.5 10.8.1, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/analysis software version 7.6.5 10.8.1/product/Becton Dickinson
Average 90 stars, based on 1 article reviews
analysis software version 7.6.5 10.8.1 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc instat version 7.00 for windows 10
Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left <t>ventricular</t> end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.
Instat Version 7.00 For Windows 10, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/instat version 7.00 for windows 10/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
instat version 7.00 for windows 10 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

86
Malvern Panalytical dispersion technology software version 7 10
Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left <t>ventricular</t> end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.
Dispersion Technology Software Version 7 10, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dispersion technology software version 7 10/product/Malvern Panalytical
Average 86 stars, based on 1 article reviews
dispersion technology software version 7 10 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

86
Malvern Panalytical zetasizer software version 7 10
Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left <t>ventricular</t> end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.
Zetasizer Software Version 7 10, supplied by Malvern Panalytical, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/zetasizer software version 7 10/product/Malvern Panalytical
Average 86 stars, based on 1 article reviews
zetasizer software version 7 10 - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

Image Search Results


Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left ventricular end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.

Journal: Regenerative Therapy

Article Title: Systemic administration of induced pluripotent stem cell-derived mesenchymal stem cells improves cardiac function through extracellular vesicle-mediated tissue repair in a rat model of ischemic cardiomyopathy

doi: 10.1016/j.reth.2024.12.008

Figure Lengend Snippet: Systemic administration of iPS-MSCs improves cardiac function in a rat ischemic cardiomyopathy model. (a) Representative images of M-mode echocardiography in the control group, iPS-MSC group, and siAlix-MSC group. (b) Ejection fraction (EF), left ventricular end-diastolic diameter (LVDd), and left ventricular end-diastolic diameter (LVD) before and 1 week after sequential administration of cells in each group (control group, n = 10; iPS-MSC group, n = 12; siAlix-MSC group; n = 9). Data are presented as mean ± SD. ∗ p < 0.05; ∗∗ p < 0.01; ∗∗∗ p < 0.001 between groups, by one-way analysis of variance with post hoc Turkey's multiple comparisons.

Article Snippet: The fibrotic area was calculated as the ratio of the total fibrotic area to the total left ventricular area using the MetaMorph software (version 7.10.3).

Techniques: Control